fluoxetine has been researched along with Complications, Pregnancy in 60 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was designed to examine whether there is an increased risk for major malformations following the use of fluoxetine during the first trimester of pregnancy." | 8.80 | Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies. ( Addis, A; Koren, G, 2000) |
| "Blood from pregnant women taking fluoxetine (n = 9), during pregnancy was sampled in the third trimester and at delivery (maternal and cord venous blood), and from the infants 48 h after delivery." | 7.73 | Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding. ( Fitzgerald, C; Grunau, RE; Kent, N; Kim, J; Misri, S; Oberlander, TF; Riggs, KW; Rurak, DW, 2006) |
| "To add to the limited data on the clinical pharmacology of antidepressants during pregnancy, we examined the dose-corrected chiral and racemic levels (level/dose) of fluoxetine (FLX) and norfluoxetine (NorFLX) during pregnancy and early postpartum." | 5.14 | Disposition of chiral and racemic fluoxetine and norfluoxetine across childbearing. ( Helsel, JC; Luther, JF; Perel, JM; Sit, D; Wisner, KL; Wisniewski, SR, 2010) |
| "To investigate the safety of fluoxetine use during pregnancy, and to better understand the relationship between maternal fluoxetine use during the first trimester and congenital malformations in infants." | 4.95 | Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studies. ( Gao, SY; Ji, C; Liu, CX; Shen, ZQ; Wu, QJ; Xu, X; Zhang, TN; Zhao, YH, 2017) |
| "The apparent increased risk of fetal cardiac malformations associated with maternal use of fluoxetine has recently been shown also in depressed women who deferred SSRI therapy in pregnancy, and therefore most probably reflects an ascertainment bias." | 4.89 | The fetal safety of fluoxetine: a systematic review and meta-analysis. ( Frankel, Z; Koren, G; Moretti, M; Pupco, A; Riggin, L, 2013) |
| "Fluoxetine was the first selective serotonin re-uptake inhibitor to be widely available for treatment of depression and numerous other neuropsychiatric disorders." | 4.82 | Safety and side effect profile of fluoxetine. ( Wernicke, JF, 2004) |
| "This study was designed to examine whether there is an increased risk for major malformations following the use of fluoxetine during the first trimester of pregnancy." | 4.80 | Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies. ( Addis, A; Koren, G, 2000) |
| "Blood from pregnant women taking fluoxetine (n = 9), during pregnancy was sampled in the third trimester and at delivery (maternal and cord venous blood), and from the infants 48 h after delivery." | 3.73 | Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding. ( Fitzgerald, C; Grunau, RE; Kent, N; Kim, J; Misri, S; Oberlander, TF; Riggs, KW; Rurak, DW, 2006) |
| " Her mother was on 20 mg of fluoxetine throughout her pregnancy." | 3.73 | Fluoxetine withdrawal syndrome in the newborn. ( Anbu, AT; Theodore, A, 2006) |
| "Prospectively identified fluoxetine-exposed pregnancies were evaluated to determine whether fluoxetine, a serotonin reuptake inhibitor commonly used for the treatment of depression and obsessive-compulsive disorder, might be associated with neonatal complications after maternal fluoxetine exposure during the third trimester through delivery." | 3.69 | Effects of third trimester fluoxetine exposure on the newborn. ( Goldstein, DJ, 1995) |
| "The rate of spontaneous pregnancy loss did not differ significantly between the women treated with fluoxetine and the control women (10." | 3.69 | Birth outcomes in pregnant women taking fluoxetine. ( Chambers, CD; Dick, LM; Felix, RJ; Johnson, KA; Jones, KL, 1996) |
| "We studied the children of 80 mothers who had received a tricyclic antidepressant drug during pregnancy, 55 children whose mothers had received fluoxetine during pregnancy, and 84 children whose mothers had not been exposed during pregnancy to any agent known to affect the fetus adversely." | 3.69 | Neurodevelopment of children exposed in utero to antidepressant drugs. ( Gardner, HA; Koren, G; Kulin, N; Nulman, I; Rovet, J; Stewart, DE; Theis, JG; Wolpin, J, 1997) |
| "Depression has a female sex predilection with 2 to 3% of the pregnant women population presently requiring treatment with selective serotonin reuptake inhibitors (SSRI)." | 2.44 | Fetal and neonatal effects of maternal drug treatment for depression. ( Belik, J, 2008) |
| "Fexofenadine is a well-identified in vivo probe substrate of P-glycoprotein (P-gp) and/or organic anion transporting polypeptide (OATP)." | 1.62 | Chiral Transplacental Pharmacokinetics of Fexofenadine: Impact of P-Glycoprotein Inhibitor Fluoxetine Using the Human Placental Perfusion Model. ( Bapat, P; Berger, H; de Carvalho Cavalli, R; de Lima Moreira, F; Koren, G; Lanchote, VL; Lubetsky, A; Pinto, L, 2021) |
| "Fluoxetine or vehicle was administered to the dam during the postpartum period via osmotic minipump implants (Alzet) for 28 days." | 1.38 | Chronic fluoxetine treatment and maternal adversity differentially alter neurobehavioral outcomes in the rat dam. ( Charlier, TD; Crispin, HT; Fillet, M; Houbart, V; Pawluski, JL; Steinbusch, HW; van den Hove, DL, 2012) |
| "Fluoxetine is an antidepressant drug, only recently discovered to be a QT interval prolonging agent." | 1.33 | Prolonged QT interval in an infant of a fluoxetine treated mother. ( Dubnov, G; Fogelman, R; Merlob, P, 2005) |
| " However, there is no data on the dosage of selective serotonin uptake inhibitors (SSRIs) required to maintain symptom resolution in women treated for major depression during pregnancy." | 1.31 | Dose of selective serotonin uptake inhibitors across pregnancy: clinical implications. ( Hostetter, A; Llewellyn, A; McLaughlin, E; Stowe, ZN; Strader, JR, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 17 (28.33) | 18.2507 |
| 2000's | 25 (41.67) | 29.6817 |
| 2010's | 14 (23.33) | 24.3611 |
| 2020's | 4 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Logue, TC | 1 |
| Wen, T | 1 |
| Huang, Y | 1 |
| Wright, JD | 1 |
| D'Alton, ME | 1 |
| Friedman, AM | 1 |
| Ramsteijn, AS | 1 |
| Jašarević, E | 1 |
| Houwing, DJ | 1 |
| Bale, TL | 1 |
| Olivier, JD | 1 |
| Svensson, M | 1 |
| Reimers, A | 1 |
| Reis, M | 1 |
| Pinto, L | 1 |
| Bapat, P | 1 |
| de Lima Moreira, F | 1 |
| Lubetsky, A | 1 |
| de Carvalho Cavalli, R | 1 |
| Berger, H | 1 |
| Lanchote, VL | 1 |
| Koren, G | 8 |
| Gao, SY | 1 |
| Wu, QJ | 1 |
| Zhang, TN | 1 |
| Shen, ZQ | 1 |
| Liu, CX | 1 |
| Xu, X | 1 |
| Ji, C | 1 |
| Zhao, YH | 1 |
| Lee, M | 1 |
| Beeson, D | 1 |
| Palace, J | 1 |
| Gemmel, M | 1 |
| De Lacalle, S | 1 |
| Mort, SC | 1 |
| Hill, LA | 1 |
| Charlier, TD | 3 |
| Pawluski, JL | 3 |
| Riggin, L | 1 |
| Frankel, Z | 1 |
| Moretti, M | 1 |
| Pupco, A | 1 |
| Morris, R | 1 |
| Matthes, J | 1 |
| Salari, AA | 1 |
| Fatehi-Gharehlar, L | 1 |
| Motayagheni, N | 1 |
| Homberg, JR | 1 |
| Kiryanova, V | 1 |
| Smith, VM | 1 |
| Dyck, RH | 1 |
| Antle, MC | 1 |
| Noorlander, CW | 1 |
| Ververs, FF | 1 |
| Nikkels, PG | 1 |
| van Echteld, CJ | 1 |
| Visser, GH | 1 |
| Smidt, MP | 1 |
| Bot, ST | 1 |
| Oh, W | 1 |
| Sedin, G | 1 |
| Belik, J | 1 |
| Sit, D | 1 |
| Perel, JM | 1 |
| Luther, JF | 1 |
| Wisniewski, SR | 1 |
| Helsel, JC | 1 |
| Wisner, KL | 2 |
| Tuccori, M | 1 |
| Montagnani, S | 1 |
| Testi, A | 1 |
| Ruggiero, E | 1 |
| Mantarro, S | 1 |
| Scollo, C | 1 |
| Pergola, A | 1 |
| Fornai, M | 1 |
| Antonioli, L | 1 |
| Colucci, R | 1 |
| Corona, T | 1 |
| Blandizzi, C | 1 |
| Patel, BN | 1 |
| Beste, J | 1 |
| Blackwell, JC | 1 |
| Fillet, M | 1 |
| Houbart, V | 1 |
| Crispin, HT | 1 |
| Steinbusch, HW | 2 |
| van den Hove, DL | 1 |
| Rayen, I | 1 |
| Hendrick, V | 3 |
| Altshuler, L | 2 |
| Nulman, I | 2 |
| Rovet, J | 2 |
| Stewart, DE | 2 |
| Wolpin, J | 2 |
| Pace-Asciak, P | 1 |
| Shuhaiber, S | 1 |
| Stowe, ZN | 2 |
| Altshuler, LL | 1 |
| Hwang, S | 1 |
| Lee, E | 2 |
| Haynes, D | 1 |
| Dai, ZY | 1 |
| Jiang, SS | 1 |
| Suri, R | 1 |
| Rasgon, N | 1 |
| Mintz, J | 1 |
| Wernicke, JF | 1 |
| Wu, CC | 1 |
| Chen, JY | 1 |
| Tao, PL | 1 |
| Chen, YA | 1 |
| Yeh, GC | 1 |
| Dubnov, G | 1 |
| Fogelman, R | 1 |
| Merlob, P | 1 |
| Morrison, JL | 2 |
| Riggs, KW | 3 |
| Rurak, DW | 2 |
| Kim, J | 1 |
| Misri, S | 1 |
| Kent, N | 1 |
| Oberlander, TF | 1 |
| Grunau, RE | 1 |
| Fitzgerald, C | 1 |
| Anbu, AT | 1 |
| Theodore, A | 1 |
| Ververs, T | 1 |
| Kaasenbrood, H | 1 |
| Visser, G | 1 |
| Schobben, F | 1 |
| de Jong-van den Berg, L | 1 |
| Egberts, T | 1 |
| Choi, JS | 1 |
| Han, JY | 1 |
| Ahn, HK | 1 |
| Shin, JS | 1 |
| Yang, JH | 1 |
| Koong, MK | 1 |
| Nava-Ocampo, AA | 1 |
| Vendittelli, F | 1 |
| Alain, J | 1 |
| Nouaille, Y | 1 |
| Brosset, A | 1 |
| Tabaste, JL | 1 |
| Goldberg, HL | 1 |
| Goldstein, DJ | 3 |
| Marvel, DE | 1 |
| Chambers, CD | 1 |
| Johnson, KA | 1 |
| Dick, LM | 1 |
| Felix, RJ | 1 |
| Jones, KL | 1 |
| Robert, E | 1 |
| Gardner, HA | 1 |
| Theis, JG | 1 |
| Kulin, N | 1 |
| Johnson, GL | 1 |
| Cohen, LS | 2 |
| Rosenbaum, JF | 1 |
| Sundell, KL | 1 |
| Corbin, LA | 1 |
| Mhanna, MJ | 1 |
| Bennet, JB | 1 |
| Izatt, SD | 1 |
| Brent, NB | 1 |
| Gupta, S | 2 |
| Rangwani, S | 2 |
| Nerhood, RC | 1 |
| Masand, PS | 1 |
| Addis, A | 1 |
| Hostetter, A | 1 |
| Strader, JR | 1 |
| McLaughlin, E | 1 |
| Llewellyn, A | 1 |
| Szigethy, EM | 1 |
| Ruiz, P | 1 |
| Calil, HM | 1 |
| Chien, C | 1 |
| Gruber, N | 1 |
| Rurak, D | 1 |
| Nonacs, R | 1 |
| Shader, RI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Antidepressant Use During Pregnancy[NCT00279370] | 283 participants (Actual) | Observational | 1999-09-30 | Completed | |||
| Transcranial Direct Current Stimulation (tDCS) for Depression in Pregnancy: A Pilot Study[NCT02116127] | 20 participants (Actual) | Interventional | 2014-04-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 reviews available for fluoxetine and Complications, Pregnancy
| Article | Year |
|---|---|
Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studies.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Depression; Female; Fluoxetin | 2017 |
Therapeutic strategies for congenital myasthenic syndromes.
Topics: Adrenergic beta-Agonists; Breast Feeding; Cholinergic Antagonists; Cholinesterase Inhibitors; Female | 2018 |
The fetal safety of fluoxetine: a systematic review and meta-analysis.
Topics: Abnormalities, Drug-Induced; Case-Control Studies; Cohort Studies; Depression; Female; Fluoxetine; H | 2013 |
Antenatal depression: guidelines for when to use pharmacotherapy.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Depression; Female; Fluoxetine; Humans; Inf | 2008 |
Fetal and neonatal effects of maternal drug treatment for depression.
Topics: Animals; Depression; Female; Fetal Diseases; Fluoxetine; Gastrointestinal Diseases; Humans; Hyperten | 2008 |
Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
Topics: Abnormalities, Drug-Induced; Cardiovascular Abnormalities; Citalopram; Depression; Female; Fluoxetin | 2010 |
Safety and side effect profile of fluoxetine.
Topics: Adolescent; Adult; Biotransformation; Bipolar Disorder; Cardiovascular Diseases; Child; Comorbidity; | 2004 |
Fluoxetine during pregnancy: impact on fetal development.
Topics: Animals; Antidepressive Agents, Second-Generation; Circadian Rhythm; Depression; Disease Models, Ani | 2005 |
Psychotropic drugs in pregnancy and lactation.
Topics: Clozapine; Embryonic and Fetal Development; Female; Fluoxetine; Humans; Lactation; Lithium; Mental D | 1994 |
Selective serotonin reuptake inhibitors in pregnancy and lactation.
Topics: Animals; Breast Feeding; Depression; Depression, Postpartum; Female; Fluoxetine; Humans; Pregnancy; | 1998 |
Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies.
Topics: Abnormalities, Drug-Induced; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; E | 2000 |
Fluoxetine: a suitable long-term treatment.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Tricyclic; Chemistry, Pharmaceutical; Child; Chi | 2001 |
Depression during pregnancy: diagnosis and treatment options.
Topics: Abnormalities, Drug-Induced; Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depress | 2002 |
1 trial available for fluoxetine and Complications, Pregnancy
| Article | Year |
|---|---|
Disposition of chiral and racemic fluoxetine and norfluoxetine across childbearing.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Female; Fluoxetine; Hum | 2010 |
46 other studies available for fluoxetine and Complications, Pregnancy
| Article | Year |
|---|---|
Continuation of psychiatric medications during pregnancy.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Depression; Female; Fluoxetine; Humans; Pharmaceutical P | 2023 |
Antidepressant treatment with fluoxetine during pregnancy and lactation modulates the gut microbiome and metabolome in a rat model relevant to depression.
Topics: Amino Acids; Animals; Antidepressive Agents, Second-Generation; Bacteria; Depression; Feces; Female; | 2020 |
[Pharmacokinetics of antidepressants during pregnancy].
Topics: Antidepressive Agents; Cytochrome P-450 CYP2D6; Female; Fluoxetine; Humans; Paroxetine; Pregnancy; P | 2020 |
Chiral Transplacental Pharmacokinetics of Fexofenadine: Impact of P-Glycoprotein Inhibitor Fluoxetine Using the Human Placental Perfusion Model.
Topics: Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; Drug Interactions; Female; Fluoxeti | 2021 |
Perinatal fluoxetine has enduring sexually differentiated effects on neurobehavioral outcomes related to social behaviors.
Topics: Animals; Female; Fluoxetine; Hippocampus; Male; Neurogenesis; Neuronal Plasticity; Pregnancy; Pregna | 2019 |
"Prozac Baby" - 25 years of motherisk research into SSRIs and alcohol in pregnancy.
Topics: Abnormalities, Drug-Induced; Alcohol Drinking; Antidepressive Agents, Second-Generation; Depression; | 2014 |
Serotonin syndrome in a breast-fed neonate.
Topics: Adult; Bottle Feeding; Breast Feeding; Depressive Disorder; Female; Fluoxetine; Humans; Infant, Newb | 2015 |
Fluoxetine normalizes the effects of prenatal maternal stress on depression- and anxiety-like behaviors in mouse dams and male offspring.
Topics: Animals; Animals, Newborn; Anxiety Disorders; Corticosterone; Depressive Disorder; Disease Models, A | 2016 |
Circadian behavior of adult mice exposed to stress and fluoxetine during development.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Circadian Rhythm; Female; Fluoxet | 2017 |
Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Cardiomyopathy, Dilated; Female; Fluoxeti | 2008 |
Maternal depression is a common complication among pregnant women occurring approximately 2-3% of this population. Introduction.
Topics: Brain Diseases; Depression; Female; Fluoxetine; Humans; Infant, Newborn; Infant, Premature; Infant, | 2008 |
Antidepressant use during pregnancy. FPIN’s clinical inquiries.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cyclo | 2011 |
Fluoxetine in early pregnancy: cardiac birth defects.
Topics: Female; Fluoxetine; Heart Defects, Congenital; Humans; Infant, Newborn; Pregnancy; Pregnancy Complic | 2011 |
Chronic fluoxetine treatment and maternal adversity differentially alter neurobehavioral outcomes in the rat dam.
Topics: Animals; Antidepressive Agents, Second-Generation; Cell Count; Corticosterone; Disease Models, Anima | 2012 |
Developmental fluoxetine exposure and prenatal stress alter sexual differentiation of the brain and reproductive behavior in male rat offspring.
Topics: Anal Canal; Animals; Brain; Ejaculation; Estradiol; Female; Fluoxetine; Genitalia, Male; Male; Midli | 2013 |
Management of major depression during pregnancy.
Topics: Adult; Antidepressive Agents; Behavior Therapy; Depressive Disorder; Female; Fluoxetine; Humans; Pre | 2002 |
Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Child; Child Behavior; Child, Preschool; De | 2002 |
Placental passage of antidepressant medications.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Fem | 2003 |
[To enhance the study of the diagnosis and treatment of psychoses during pregnancy and postpartum stage].
Topics: Antidepressive Agents, Second-Generation; Female; Fluoxetine; Humans; Postpartum Period; Pregnancy; | 2003 |
Neonatal complications after intrauterine exposure to SSRI antidepressants.
Topics: Antidepressive Agents; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; F | 2004 |
The impact of depression and fluoxetine treatment on obstetrical outcome.
Topics: Adult; Antidepressive Agents, Second-Generation; Case-Control Studies; Confidence Intervals; Depress | 2004 |
Serotonin reuptake inhibitors attenuate morphine withdrawal syndrome in neonatal rats passively exposed to morphine.
Topics: Animals; Animals, Newborn; Behavior, Animal; Citalopram; Clomipramine; Female; Fluoxetine; Maternal- | 2005 |
Prolonged QT interval in an infant of a fluoxetine treated mother.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Electrocardiography; Female; Fluoxeti | 2005 |
Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding.
Topics: Adult; Aging; Antidepressive Agents, Second-Generation; Breast Feeding; Depressive Disorder, Major; | 2006 |
Fluoxetine withdrawal syndrome in the newborn.
Topics: Depressive Disorder; Female; Fluoxetine; Follow-Up Studies; Humans; Infant, Newborn; Neonatal Abstin | 2006 |
Prevalence and patterns of antidepressant drug use during pregnancy.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents; Benzodiazepines; Databases, Factual; Depressi | 2006 |
Exposure to rosiglitazone and fluoxetine in the first trimester of pregnancy.
Topics: Adult; Diabetes Mellitus, Type 2; Female; Fluoxetine; Humans; Hypoglycemic Agents; Infant; Infant, N | 2006 |
A case of lipomeningocele reported with fluoxetine (and alprazolam, vitamins B1 and B6, heptaminol) prescribed during pregnancy.
Topics: Adult; Alprazolam; Depression; Drug Therapy, Combination; Female; Fluoxetine; Heptaminol; Humans; In | 1995 |
Psychotropic medications during pregnancy: risk to the fetus.
Topics: Abnormalities, Drug-Induced; Female; Fluoxetine; Humans; Pregnancy; Pregnancy Complications; Pregnan | 1993 |
Effects of third trimester fluoxetine exposure on the newborn.
Topics: Abnormalities, Drug-Induced; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; D | 1995 |
Birth outcomes in pregnant women taking fluoxetine.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Affective Symptoms; Birth Weight; Case-Co | 1996 |
Treating depression in pregnancy.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Depression; Female; Fluoxetine; Humans; Infant, | 1996 |
First-trimester exposure to fluoxetine (prozac). Does it affect pregnancy outcome?
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Fluoxetine; Humans; Pregnancy | 1996 |
Neurodevelopment of children exposed in utero to antidepressant drugs.
Topics: Adult; Antidepressive Agents, Tricyclic; Aptitude Tests; Child; Child Behavior; Child, Preschool; De | 1997 |
Birth outcomes in pregnant women taking fluoxetine.
Topics: Abnormalities, Drug-Induced; Adult; Clinical Trials as Topic; Depression; Female; Fluoxetine; Humans | 1997 |
Birth outcomes in pregnant women taking fluoxetine.
Topics: Abnormalities, Drug-Induced; Female; Fluoxetine; Humans; Infant, Newborn; Infant, Newborn, Diseases; | 1997 |
Birth outcomes in pregnant women taking fluoxetine.
Topics: Abnormalities, Drug-Induced; Female; Fluoxetine; Humans; Infant, Newborn; Infant, Newborn, Diseases; | 1997 |
Potential fluoxetine chloride (Prozac) toxicity in a newborn.
Topics: Adult; Antidepressive Agents, Second-Generation; Female; Fetus; Fluoxetine; Follow-Up Studies; Human | 1997 |
Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Breast Feeding; Carbamazepine; Female; Fluoxetine; Humans; | 1998 |
SSRIs in pregnancy.
Topics: Abnormalities, Drug-Induced; Animals; Depressive Disorder; Female; Fluoxetine; Humans; Infant, Newbo | 1998 |
Fluoxetine and pregnancy a safe mix?
Topics: Depression; Female; Fibromyalgia; Fluoxetine; Humans; Pregnancy; Pregnancy Complications; Safety; Se | 1998 |
Dose of selective serotonin uptake inhibitors across pregnancy: clinical implications.
Topics: Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; | 2000 |
Depression among pregnant adolescents: an integrated treatment approach.
Topics: Adolescent; Combined Modality Therapy; Depressive Disorder; Electroconvulsive Therapy; Female; Fluox | 2001 |
SSRIs in pregnancy--are they safe?
Topics: Animals; Antidepressive Agents, Second-Generation; Contraindications; Depression; Female; Fetus; Flu | 2002 |
Effect of maternal fluoxetine administration on uterine blood flow, fetal blood gas status, and growth.
Topics: Acid-Base Equilibrium; Animals; Antidepressive Agents, Second-Generation; Blood Gas Analysis; Blood | 2002 |
A patient of mine missed a period while taking fluoxetine; it turned out that she was not pregnant. However, the question arose about the safety of fluoxetine during pregnancy. What is known?
Topics: Dysmenorrhea; Female; Fluoxetine; Humans; Pregnancy; Pregnancy Complications | 1992 |